Disease Network Specialist, Rare Endocrinology, EU Center

The role

You will drive strategic initiatives to improve diagnosis rates of autosomal dominant hypocalcemia type 1 by building disease awareness and supporting diagnostic pathways. You will work across a network of endocrinology centers, hospital departments, and office-based practices.

What you will do

• Build and maintain a network across hospital endocrinology departments, MVZ and office-based endocrinologists
• Raise awareness of ADH1 among physicians managing hypoparathyroidism
• Share guideline-aligned diagnostic algorithms and approved disease education materials
• Support HCPs with the logistics of genetic testing
• Work with MSLs on joint account plans and provide operational support
• Capture field insights on diagnostic gaps and referral patterns in CRM
• Operate within HWG, industry codes and company policy

Required qualifications

• Qualification as Pharmaberater according to § 75 AMG, e.g. a degree in life sciences, pharmacy or medicine, or certified Pharmareferent/in
• At least 5 years of field experience in pharma or biotech
• Established network among hospital and office-based endocrinologists in Germany
• Sound knowledge of HWG and industry codes
• Fluent German
• Good English
• Valid driving license
• Willingness to travel 60-70% of the time

Nice to have

• Experience in rare diseases, endocrinology or nephrology
• Experience in a key account management or disease awareness role
• Experience with genetic testing, diagnostic pathways or rare disease diagnostic support programs

Benefits

• Market leading compensation
• Hybrid work model
• Career development through regular feedback, continuous education and professional development programs
• Financial rewards for strong performance
• Peer-to-peer recognition
• Growth opportunities

About the company

BridgeBio uses a moneyball for biotech approach, pooling projects and promising early-stage research from academia to reduce risk and unleash innovation. They build bridges to groundbreaking advancements in rare disease and develop medicines for patients with unmet needs.